ATyr Pharma Valuation
| LIFE Stock | USD 1.64 0.04 2.50% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. aTyr Pharma shows a prevailing Real Value of $6.98 per share. The current price of the firm is $1.64. Our model approximates the value of aTyr Pharma from analyzing the firm fundamentals such as Current Valuation of 25.14 M, return on equity of -0.62, and Shares Outstanding of 67.94 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will blend. Key fundamental drivers impacting ATyr Pharma's valuation include:
Price Book 1.304 | Enterprise Value 25.1 M | Enterprise Value Ebitda (0.67) | Price Sales 334.8923 | Enterprise Value Revenue 99.5639 |
Undervalued
Today
Please note that ATyr Pharma's price fluctuation is moderately volatile at this time. Calculation of the real value of aTyr Pharma is based on 3 months time horizon. Increasing ATyr Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for aTyr Pharma is useful when determining the fair value of the ATyr stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of ATyr Pharma. Since ATyr Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ATyr Stock. However, ATyr Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.64 | Real 6.98 | Target 23.2 | Hype 1.72 |
The real value of ATyr Stock, also known as its intrinsic value, is the underlying worth of aTyr Pharma Company, which is reflected in its stock price. It is based on ATyr Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of ATyr Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence ATyr Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of aTyr Pharma helps investors to forecast how ATyr stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ATyr Pharma more accurately as focusing exclusively on ATyr Pharma's fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ATyr Pharma's intrinsic value based on its ongoing forecasts of ATyr Pharma's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ATyr Pharma's closest peers. When choosing an evaluation method for aTyr Pharma, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
ATyr Pharma Investments |
|
ATyr Valuation Trend
Knowing ATyr Pharma's actual value is paramount for traders to make sound investment determinations. ATyr Pharma's real value is not only important for the investor to make better decisions but also for a more accurate overall view of ATyr Pharma's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both ATyr Pharma's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
ATyr Market Cap
aTyr Pharma is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is now estimated at about 3.06 Billion. ATyr Pharma holds roughly 108.71 Million in market capitalization claiming about 4% of equities under Health Care industry.ATyr Pharma Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining ATyr Pharma's current stock value. Our valuation model uses many indicators to compare ATyr Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ATyr Pharma competition to find correlations between indicators driving ATyr Pharma's intrinsic value. More Info.aTyr Pharma is rated fifth overall in price to earning category among related companies. It is rated below average in price to book category among related companies . As of April 23, 2024, Price To Book Ratio is expected to decline to 0.79. Comparative valuation analysis is a catch-all model that can be used if you cannot value ATyr Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ATyr Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ATyr Pharma's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ATyr Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ATyr Pharma and how it compares across the competition.
About ATyr Pharma Valuation
The stock valuation mechanism determines the current worth of aTyr Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of aTyr Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of aTyr Pharma based exclusively on its fundamental and basic technical indicators. By analyzing ATyr Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of ATyr Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of ATyr Pharma. We calculate exposure to ATyr Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ATyr Pharma's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -2.4 M | -2.3 M | |
| Pretax Profit Margin | (142.77) | (135.63) | |
| Operating Profit Margin | (155.58) | (147.80) | |
| Net Loss | (142.75) | (135.61) | |
| Gross Profit Margin | (6.76) | (7.10) |
8 Steps to conduct ATyr Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates ATyr Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct ATyr Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain ATyr Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine ATyr Pharma's revenue streams: Identify ATyr Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research ATyr Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish ATyr Pharma's growth potential: Evaluate ATyr Pharma's management, business model, and growth potential.
- Determine ATyr Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate ATyr Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
ATyr Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as ATyr Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 53.6 M |
ATyr Pharma Current Valuation Indicators
Valuation refers to the process of determining the present value of aTyr Pharma and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ATyr we look at many different elements of the entity such as ATyr's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. ATyr Pharma's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final ATyr Pharma's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ATyr Pharma, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ATyr Pharma's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ATyr Pharma's worth.When determining whether aTyr Pharma is a strong investment it is important to analyze ATyr Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ATyr Pharma's future performance. For an informed investment choice regarding ATyr Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in aTyr Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.94) | Revenue Per Share 0.007 | Quarterly Revenue Growth (1.00) | Return On Assets (0.32) | Return On Equity (0.62) |
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.